NISH (NITAG Support Hub) 4: HPV OR Human Papillomavirus Vaccines: Other significant resources and publications on HPV Vaccines

Amukogo, H.J., Rungayi, B.R. and Karera, A., 2018. Awareness, knowledge, attitude and practices regarding human papilloma virus among female students at the University of Namibia. Int J Healthcare, 4(2).  https://d1wqtxts1xzle7.cloudfront.net/81270767/8707-libre.pdf?1645594877=&response-content-disposition=inline%3B+filename%3DAwareness_knowledge_attitude_and_practic.pdf&Expires=1682591679&Signature=DijPtkpPhHafbn~ojwcuNz2b

Aragaw, G. M., Anteneh, T. A., Abiy, S. A., Bewota, M. A., & Aynalem, G. L. (2023). Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A  community-based cross-sectional study. Human Vaccines & Immunotherapeutics, 19(1), 2176082. https://doi.org/10.1080/21645515.2023.2176082

Baisley, K., Kemp, T. J., Mugo, N. R., Whitworth, H., Onono, M. A., Njoroge, B., Indangasi, J., Bukusi, E. A., Prabhu, P. R., Mutani, P., Galloway, D. A., Mwanzalime, D., Kapiga, S., Lacey, C. J., Hayes, R. J., Changalucha, J., Pinto, L. A., Barnabas, R. V., & Watson-Jones, D. (2024). Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): An  immunobridging analysis of randomised controlled trials. The Lancet. Global Health, 12(3), e491–e499. https://doi.org/10.1016/S2214-109X(23)00586-7

Barnabas, R. V., Brown, E. R., Onono, M. A., Bukusi, E. A., Njoroge, B., Winer, R. L., Galloway, D. A., Pinder, L. F., Donnell, D., N Wakhungu, I., Biwott, C., Kimanthi, S., Heller, K. B., Kanjilal, D. G., Pacella, D., Morrison, S., A Rechkina, E., L Cherne, S., Schaafsma, T. T., … Mugo, N. R. (2023). Durability of single-dose HPV vaccination in young Kenyan women: Randomized controlled trial 3-year results. Nature Medicine, 29(12), 3224–3232. https://doi.org/10.1038/s41591-023-02658-0

Baisley, K.J., Whitworth, H.S., Changalucha, J., Pinto, L., Dillner, J., Kapiga, S., de Sanjosé, S., Mayaud, P., Hayes, R.J., Lacey, C.J. and Watson-Jones, D., 2021. A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial)–Study protocol for a randomised controlled trial. Contemporary clinical trials, 101, p.106266.  https://doi.org/10.1016/j.cct.2021.106266

Baussano, I., Sayinzoga, F., Tshomo, U., Tenet, V., Vorsters, A., Heideman, D.A., Gheit, T., Tommasino, M., Umulisa, M.C., Franceschi, S. and Clifford, G.M., 2021. Impact of human papillomavirus vaccination, Rwanda and Bhutan. Emerging Infectious Diseases, 27(1), p.1.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774553/

Bénard, É., Drolet, M., Laprise, J.-F., Gingras, G., Jit, M., Boily, M.-C., Bloem, P., & Brisson, M. (2023). Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: A mathematical modelling analysis. The Lancet. Public Health, 8(10), e788–e799. https://doi.org/10.1016/S2468-2667(23)00180-9

Bila, T., Wendling, G., & Schwartzbrod, P.-E. (2014). Pathologies buccales à papilloma virus humain en dehors d’une contamination sexuelle : à propos de 3 patients. Médecine Buccale Chirurgie Buccale, 20(3), 193–201. (NOT OA)

Abstract:

The human papilloma virus is responsible for many kinds of proliferative lesions of the oral mucosa. The aim of this article is to assess two pathologies among the most frequently observed, condyloma acuminate and focal oral hyperplasia. From the study of three young girls seen in a mission in Chad, and a literature survey, we consider the epidemiological chain, by describing the lesions, and specifying their pathogenesis and their mode of transmission, leading to positive and differential diagnoses and the therapeutic aspects. This case report shows a departure from the conventional theory of transmission by sexual contact, and the consequences of this for children. [ABSTRACT FROM AUTHOR]

Abstract (French):

Le papilloma virus est responsable de différents types de lésions prolifératives de la muqueuse buccale. Cet article permet de faire le point concernant deux types de pathologies parmi les plus fréquemment rencontrées dans ce contexte, les condylomes acuminés et l'hyperplasie épithéliale focale. À partir de l'étude de trois observations cliniques réalisées au Tchad, et d'une revue de la littérature, nous envisageons la chaîne épidémiologique, en décrivant les lésions, en précisant leur pathogénie et leur mode de transmission, cette demarche aboutissant à l'évocation des diagnostics positif et différentiel et débouchant sur les aspects thérapeutiques. L'originalité de ce travail repose sur une séparation avec les théories classiques de la transmission par voie essentiellement sexuelle, et leurs conséquences chez l'enfant. [ABSTRACT FROM AUTHOR]

 

Binagwaho, A., Wagner, C.M., Gatera, M., Karema, C., Nutt, C.T. and Ngabo, F., 2012. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bulletin of the World Health Organization, 90, pp.623-628.   https://www.scielosp.org/article/ssm/content/raw/?resource_ssm_path=/media/assets/bwho/v90n8/a14v90n8.pdf

Dera, M., Wondimagegnehu, A., & Asfaw, Z. G. (2023). Determinants for hesitancy in human papillomavirus (HPV) vaccine uptake among school girls in Jimma Town, Ethiopia. A mixed approach: Quantitative and  qualitative. Reproductive Health, 20(1), 175. https://doi.org/10.1186/s12978-023-01711-y

Dreyer, G., Botha, M.H., Snyman, L.C., Visser, C., Burden, R., Laubscher, N., Grond, B., Richter, K., Becker, P.J., Harvey, J. and van der Merwe, F.H., 2022. Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials. International Journal of Gynecologic Cancer, 32(5).   http://dx.doi.org/10.1136/ijgc-2021-003079

Engel, D., Afeli, A.D.J., Morgan, C., Zeck, W., Ross, D.A., Vyankandondera, J., Bloem, P. and Adjeoda, K.R., 2022. Promoting adolescent health through integrated human papillomavirus vaccination programs: the experience of Togo. Vaccine, 40, pp.A100-A106. https://doi.org/10.1016/j.vaccine.2021.11.021

Ferré, Valentine Marie, Fifonsi A. Gbeasor-Komlanvi, Gilles Collin, Anoumou Claver Dagnra, Quentin Le Hingrat, Antoine Jaquet, Mounerou Salou, Diane Descamps, Charlotte Charpentier, and Didier Koumavi Ekouevi. "Prevalence of human papillomavirus, human immunodeficiency virus, and other sexually transmitted infections among men who have sex with men in Togo: a national cross-sectional survey." Clinical Infectious Diseases 69, no. 6 (2019): 1019-1026.

Gamaoun, R., 2018. National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case. Vaccine, 36(33), pp.5091-5096. (NOT OA)

Ghebrendrias, S., Mody, S., Washington, S., Hussein, B., Jama, F., & Jacobs, M. (2023). A Cervical Cancer Screening Toolkit for Somali Women: A Pilot Randomized Controlled Trial. Journal of Immigrant and Minority Health, 25(6), 1307–1314. https://doi.org/10.1007/s10903-023-01455-8

Guenou, E., Wakam Nkontchou, B., Vouking Zambou, M., Buh Nkum, C., Mfoulou Minso, A. C., Napa, Y. L., Beyala Bita’a, L., Murhabazi Bashombwa, A., Tchio-Nighie, K. H., Ateudjieu, J., & d’Alessandro, E. (2024). Acceptability and Feasibility of Human Papillomavirus Vaccine Introduction in Cameroon: A Mixed-Methods Study. Cureus, 16(5), e60723. https://doi.org/10.7759/cureus.60723

Hsiao, A., Struckmann, V., Stephani, V., Mmbando, D., Changalucha, J., Baisley, K., Levin, A., Morgan, W., Hutubessy, R., Watson–Jones, D. and Whitworth, H., 2023. Costs of delivering human papillomavirus vaccination using a one-or two-dose strategy in Tanzania. Vaccine, 41(2), pp.372-379.  https://doi.org/10.1016/j.vaccine.2022.11.032

Islam, J.Y., Hoyt, A.M., Ramos, S., Morgan, K., Kim, C.J., de Sanjose, S., Butera, N., Senkomago, V., Richter, K.L., McDonald, M.A. and Vielot, N.A., 2018. Acceptability of two-versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries. Cancer Causes & Control, 29, pp.1115-1130. (NOT OA)

Kabarambi, A., Kizito, S., Hunleth, J., Silver, M. I., Niyonzima, N., & Ssewamala, F. (2025). HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women Living with HIV-in Central Uganda. AIDS and Behavior, 1-7. https://doi.org/10.1007/s10461-025-04654-6

Kiendrébéogo, J. A., Sidibe, A. R. O., Compaoré, G. B., Nacanabo, R., Sory, O., Ouédraogo, I., Nawaz, S., Schuind, A. E., & Clark, A. (2023). Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: A modelling study. BMC Health Services Research, 23(1), 1338. https://doi.org/10.1186/s12913-023-10283-3

Kombe, A. J. K., Zoa-Assoumou, S., Bounda, G.-A., Nsole-Biteghe, F.-A., Jin, T., & Zouré, A. A. (2023). Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis. Frontiers in Bioscience (Landmark Edition), 28(10), 245. https://doi.org/10.31083/j.fbl2810245

Kpokiri, E. E., Wapmuk, A. E., Obiezu-Umeh, C., Nwaozuru, U., Gbaja-Biamila, T., Obionu, I., Kokelu, E., Smith, J., Azuogu, B. N., Ajenifuja, K., Babatunde, A. O., Ezechi, O., Tucker, J. D., & Iwelunmor, J. (2024). A designathon to co-create HPV screening and vaccination approaches for mothers and daughters in Nigeria: Findings from a community-led participatory event. BMC Infectious Diseases, 24(1), 606. https://doi.org/10.1186/s12879-024-09479-7

Kpokiri, E. E., Wapmuk, A., Obiezu-Umeh, C., Nwaozuru, U., Gbaja-Biamila, T., Obionu, I., Kokelu, E., Smith, J., Benedict, A. N., Ajenifuja, K., Babatunde, A. O., Ezechi, O., Tucker, J. D., & Iwelunmor, J. (2024). A designathon to co-create HPV screening and vaccination approaches for mothers and daughters in Nigeria: Findings from a community-led participatory event. https://doi.org/10.21203/rs.3.rs-3829727/v1

Louie, K.S., De Sanjose, S. and Mayaud, P., 2009. Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review. Tropical Medicine & International Health, 14(10), pp.1287-1302. https://doi.org/10.1111/j.1365-3156.2009.02372.x

Lubeya, M. K., Chibwesha, C. J., Mwanahamuntu, M., Mukosha, M., Vwalika, B., & Kawonga, M. (2023). Determinants of the Implementation of Human Papillomavirus Vaccination in Zambia: Application of the Consolidated Framework for Implementation Research. Vaccines, 12(1). https://doi.org/10.3390/vaccines12010032

Nyasenu, Y.T., Gbeasor-Komlanvi, F.A., Ehlan, A., Issa, S.A.R., Dossim, S., Kolou, M., Yambiyo, B.M., Prince-David, M., Salou, M., Ekouevi, D.K. and Dagnra, A., 2019. Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo. PloS one, 14(2), p.e0212516.  https://doi.org/10.1371/journal.pone.0212516

Machalek, D., Rees, H., Chikandiwa, A., Munthali, R., Travill, D., Mbulawa, Z., Petoumenos, K., Delany-Moretlwe, S. and Kaldor, J., 2022. Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design. BMJ open, 12(2), p.e059968.   DOI: 10.1136/bmjopen-2021-059968

Marembo, T., Fitzpatrick, M. B., & Dube Mandishora, R. S. (2024). Human papillomavirus genotype distribution patterns in Zimbabwe; is the bivalent vaccine sufficient? Intervirology, 67(1), 55–63. https://doi.org/10.1159/000531347

Mboumba Bouassa, R.S., Nodjikouambaye, Z.A., Sadjoli, D., Adawaye, C., Péré, H., Veyer, D., Matta, M., Robin, L., Tonen-Wolyec, S., Moussa, A.M. and Koyalta, D., 2019. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad. PLoS One, 14(6), p.e0217486.   https://doi.org/10.1371/journal.pone.0217486

Michelow, P. and Firnhaber, C., 2016. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer. Cancer Cytopathology, 124(10), pp.695-698.    https://doi.org/10.1002/cncy.21738

Msyamboza, K.P., Mwagomba, B.M., Valle, M., Chiumia, H. and Phiri, T., 2017. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges. BMC Public Health, 17(1), pp.1-7.   https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4526-y

Mungo, C., Adewumi, K., Adoyo, E., Zulu, G., Goraya, S. K., Ogollah, C., Omoto, J., Ferrari, R. M., & Rahangdale, L. (2023). “There is nothing that can prevent me from supporting her:” Men’s perspectives on their involvement and support of women’s use of topical therapy for cervical  precancer treatment in Kenya. In medRxiv: The preprint server for health sciences (p. 2023.12.22.23300455). https://doi.org/10.1101/2023.12.22.23300455

Mungo, C., Adewumi, K., Adoyo, E., Zulu, G., Goraya, S. K., Ogollah, C., Omoto, J., Ferrari, R. M., & Rahangdale, L. (2024). “There is nothing that can prevent me from supporting her:” men’s perspectives on their involvement and support of women’s use of topical therapy for cervical  precancer treatment in Kenya. Frontiers in Oncology, 14, 1360337. https://doi.org/10.3389/fonc.2024.1360337

Murahwa, A. T., Mudzviti, T., Mandishora, R. S. D., Chatindo, T., Chanetsa, P., Pascoe, M., Shamu, T., Basera, W., Luethy, R., & Williamson, A.-L. (2024). Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD  Cohort. Viruses, 16(1). https://doi.org/10.3390/v16010162

Sørbye, S. W., Falang, B. M., Botha, M. H., Snyman, L. C., van der Merwe, H., Visser, C., Richter, K., & Dreyer, G. (2023). Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations. Cancers, 15(22). https://doi.org/10.3390/cancers15225453

Tan, N., Sharma, M., Winer, R., Galloway, D., Rees, H. and Barnabas, R.V., 2018. Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. Vaccine, 36(32), pp.4830-4836.   https://doi.org/10.1016/j.vaccine.2018.02.023

Tran, J., Hathaway, C. L., Broshkevitch, C. J., Palanee-Phillips, T., Barnabas, R. V., Rao, D. W., & Sharma, M. (2024). Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: A model-based analysis accounting for the HIV epidemic. Frontiers in Oncology, 14, 1382599. https://doi.org/10.3389/fonc.2024.1382599

Wassie, M., Zegeye, A. F., Worku, W., Sisay, T., Eyob, T., & Gebeyehu, D. A. (2023). Willingness to accept human papilloma virus vaccination and its associated factors among parents with eligible daughters in Addis Zemen town, Northwest  Ethiopia. Infectious Agents and Cancer, 18(1), 84. https://doi.org/10.1186/s13027-023-00551-6

Zhang, S., Kwach, B., Omollo, V., Asewe, M., Malen, R. C., Shah, P. D., Odoyo, J., Mugo, N., Ngure, K., Bukusi, E. A., & Ortblad, K. F. (2023). The Acceptability of Pharmacy-Based HPV Vaccination in Western Kenya among Pharmacy Clients and Providers. Vaccines, 11(12). https://doi.org/10.3390/vaccines11121808